Becker Hewes
Impact in
Papers in
-
- Advanced Breast Cancer Therapies 12
- Oncology 13
- Cancer Treatment and Pharmacology 3
- Co-authors
- Scott B. Cameron (1 shared paper)Philip J. Gotwals (1 shared paper)Glenn Dranoff (1 shared paper)Catherine Sabatos-Peyton (1 shared paper)Viviana Cremasco (1 shared paper)Lilli Petruzzelli (1 shared paper)Daniela Cipolletta (1 shared paper)Jeffrey A. Engelman (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Blood (6 papers)Cancer Research (5 papers)Human Gene Therapy (2 papers)Nature reviews. Cancer (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Becker Hewes
34 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Genetics 457
- Oncology 1000
- Immunology 624
- Pathology and Forensic Medicine 388
- Hematology 216
Countries citing papers authored by Becker Hewes
This map shows the geographic impact of Becker Hewes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becker Hewes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becker Hewes more than expected).
Fields of papers citing papers by Becker Hewes
This network shows the impact of papers produced by Becker Hewes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becker Hewes. The network helps show where Becker Hewes may publish in the future.
Co-authors
The 25 scholars most cited alongside Becker Hewes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prospects for combining targeted and conventional cancer therapy with immunotherapy Hit paper breakdown → | 2017 | 766 |
| 2 | Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Hit paper breakdown → | 2009 | 485 |
| 3 | 2016 | 165 | |
| 4 | 2007 | 132 | |
| 5 | 2006 | 42 | |
| 6 | 2010 | 36 | |
| 7 | 2016 | 30 | |
| 8 | 2017 | 30 | |
| 9 | 2014 | 28 | |
| 10 | 2007 | 27 | |
| 11 | 2007 | 27 | |
| 12 | 2007 | 27 | |
| 13 | 2008 | 23 | |
| 14 | 2014 | 21 | |
| 15 | 2014 | 19 | |
| 16 | 2007 | 17 | |
| 17 | 2007 | 17 | |
| 18 | 2011 | 17 | |
| 19 | 2016 | 16 | |
| 20 | 2015 | 15 |
About Becker Hewes
Becker Hewes is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Hematology and Rheumatology, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (8 papers), Eosinophilic Disorders and Syndromes (6 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Genetics (457 citations), Oncology (1000 citations), Immunology (624 citations), Pathology and Forensic Medicine (388 citations) and Hematology (216 citations). Becker Hewes has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Scott B. Cameron, Philip J. Gotwals, Glenn Dranoff, Catherine Sabatos-Peyton, Viviana Cremasco, Lilli Petruzzelli, Daniela Cipolletta, Jeffrey A. Engelman, Sonia Quaratino and Britta Mueller. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Human Gene Therapy and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.